Lebrikizumab treatment leads to encouraging outcomes in multiple traits of AD Presented ByProf. Jonathan Silverberg, George Washington University School of Medicine, USA TrialPhase 3, ADvocate1; ADvocate2 ConferenceAAD 2022 17 May, 2022 12:18
